18606.8077615306 14 Smiths Group Analyst Ratings and Earnings History | $SMIN | LON:SMIN | Analyst Ratings Network

Analysts' Ratings and Earnings for Smiths Group

Share on StockTwits

Lookup Another Company:  :  

Quick Links: Consensus Ratings, Ratings History, Earnings History, Company Description
Consensus Ratings for Smiths Group (LON:SMIN) (?)
Ratings Breakdown: 3 Sell Rating(s), 5 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Hold
Consensus Price Target: GBX 1,329.06

Analysts' Ratings History for Smiths Group (LON:SMIN)
DateFirmActionCompanyOld RatingNew RatingOld Price TargetNew Price TargetDetails
5/8/2013JP Morgan CazenoveReiterated RatingSmiths Group (SMIN)OverweightOverweightGBX 1,500GBX 1,500View
4/4/2013WH IrelandReiterated RatingSmiths Group (SMIN)OutperformView
3/27/2013Deutsche BankBoost Price TargetSmiths Group (SMIN)BuyGBX 1,370.12GBX 1,389.98View
3/27/2013Barclays CapitalReiterated RatingSmiths Group (SMIN)UnderweightGBX 1,148.72View
3/22/2013Societe GeneraleReiterated RatingSmiths Group (SMIN)SellGBX 1,181.51View
3/22/2013JPMorgan ChaseBoost Price TargetSmiths Group (SMIN)OverweightGBX 1,294.74GBX 1,476.89View
3/22/2013Arden Partners LtdDowngradeSmiths Group (SMIN)NeutralGBX 1,279.97View
3/22/2013UBS AGBoost Price TargetSmiths Group (SMIN)NeutralGBX 1,279.97GBX 1,329.20View
3/21/2013JP Morgan CazenoveBoost Price TargetSmiths Group (SMIN)OverweightGBX 1,294.74GBX 1,476.89View
3/21/2013RBC CapitalReiterated RatingSmiths Group (SMIN)UnderperformView
3/21/2013Espirito Santo Investment Bank ResearchBoost Price TargetSmiths Group (SMIN)NeutralGBX 945.21GBX 1,201.20View
3/21/2013HB MarketsReiterated RatingSmiths Group (SMIN)HoldView
3/21/2013Deutsche BankReiterated RatingSmiths Group (SMIN)BuyGBX 1,358.74GBX 1,358.74View
3/20/2013Credit SuisseReiterated RatingSmiths Group (SMIN)OutperformGBX 1,398.12GBX 1,398.12View
3/20/2013Morgan StanleyReiterated RatingSmiths Group (SMIN)Equal WeightGBX 1,261.26GBX 1,261.26View
3/19/2013HSBCReiterated RatingSmiths Group (SMIN)OverweightGBX 1,378.43GBX 1,378.43View
3/15/2013Deutsche BankBoost Price TargetSmiths Group (SMIN)BuyGBX 1,314.43GBX 1,358.74View
3/13/2013Deutsche BankBoost Price TargetSmiths Group (SMIN)BuyGBX 1,314.43GBX 1,358.74View
3/15/2013Societe GeneraleReiterated RatingSmiths Group (SMIN)sellGBX 1,143.76View
3/14/2013BNP ParibasReiterated RatingSmiths Group (SMIN)OutperformGBX 1,338.45View
3/13/2013Deutsche BankBoost Price TargetSmiths Group (SMIN)BuyGBX 1,299.51GBX 1,343.32View
3/8/2013Barclays CapitalReiterated RatingSmiths Group (SMIN)UnderweightGBX 1,070.76GBX 1,070.76View
3/8/2013Barclays CapitalReiterated RatingSmiths Group (SMIN)UnderweightGBX 1,077.84GBX 1,077.84View
2/25/2013Morgan StanleyReiterated RatingSmiths Group (SMIN)Equal WeightGBX 1,261.64View
2/15/2013Morgan StanleyBoost Price TargetSmiths Group (SMIN)Equal WeightGBX 1,136.16GBX 1,293.70View
1/29/2013Jefferies GroupReiterated RatingSmiths Group (SMIN)BuyGBX 1,432.08View
12/14/2012Deutsche BankUpgradeSmiths Group (SMIN)BuyView
12/4/2012Reiterated RatingSmiths Group (SMIN)OutperformGBX 1,291View
9/21/2012JPMorgan ChaseReiterated RatingSmiths Group (SMIN)OverweightGBX 1,398.22View
9/20/2012Arden Partners LtdUpgradeSmiths Group (SMIN)AddGBX 1,208.98View
9/19/2012Credit SuisseReiterated RatingSmiths Group (SMIN)OutperformGBX 1,261.55View
9/17/2012Reiterated RatingSmiths Group (SMIN)outperformGBX 1,261.55View
9/10/2012RBC CapitalUpgradeSmiths Group (SMIN)UnderperformGBX 919.88View
8/28/2012Reiterated RatingSmiths Group (SMIN)OutperformGBX 1,241.52View
Click Here to view only the most recent ratings from each analyst for this stock.

Earnings History for Smiths Group (LON:SMIN)
No earnings history available

About Smiths Group
Smiths Group plc is a technology company. It has five divisions: Smiths Detection, Smiths Medical, John Crane, Smiths Interconnect and Flex-Tek. The Company and its subsidiaries develop, manufacture, sale and support advanced security equipment, including trace detection, millimeter-wave, infrared, biological detection and diagnostics; mechanical seals, seal support systems, engineered bearings, power transmission couplings and specialist filtration systems, and medical devices aligned to specific therapies, principally airway, pain and temperature management, and vascular access. It also develops, manufactures, sells and supports specialized electronic and radio frequency products for the global wireless telecommunications, aerospace, defense, space, medical, rail, test and industrial markets, and engineered components, including ducting, hose assemblies and heating elements. In May 2011, it acquired the entire issued share capital of SDBR Comercio De Equipamentos De Seguanca LTDA.


© Analyst Ratings Network 2006-2012. All rights reserved.